Doxorubicin-loaded nanospheres bypass tumor cell multidrug resistance.
about
Exploiting nanotechnology to overcome tumor drug resistance: Challenges and opportunitiesCancer nanotheranostics: improving imaging and therapy by targeted delivery across biological barriers.Small and Innovative Molecules as New Strategy to Revert MDRReversal in multidrug resistance by magnetic nanoparticle of Fe3O4 loaded with adriamycin and tetrandrine in K562/A02 leukemic cellsPolyethyleneimine-modified iron oxide nanoparticles for brain tumor drug delivery using magnetic targeting and intra-carotid administration.Oxygen as a regulator of cellular phenotypes in pregnancy and cancer.Enhanced tumour cell nuclear targeting in a tumour progression model.Cationic albumin nanoparticles for enhanced drug delivery to treat breast cancer: preparation and in vitro assessment.Novel drug delivery systems: desired feat for tuberculosis.Anthracycline Nano-Delivery Systems to Overcome Multiple Drug Resistance: A Comprehensive Review.Design opportunities for actively targeted nanoparticle vaccines.pH-responsive mesoporous silica nanoparticles employed in controlled drug delivery systems for cancer treatment.Clinical developments in nanotechnology for cancer therapy.Nanopreparations to overcome multidrug resistance in cancer.Synthesis and evaluation of pH-sensitive, self-assembled chitosan-based nanoparticles as efficient doxorubicin carriers.The Tumor Microenvironment as a Barrier to Cancer Nanotherapy.Paclitaxel-loaded poly(n-butylcyanoacrylate) nanoparticle delivery system to overcome multidrug resistance in ovarian cancer.Development and in vitro characterization of galactosylated low molecular weight chitosan nanoparticles bearing doxorubicin.Evaluating the potential of polymer nanoparticles for oral delivery of paclitaxel in drug-resistant cancer.Self-assembled polyethylenimine-graft-poly(epsilon-caprolactone) micelles as potential dual carriers of genes and anticancer drugs.The activity of doxorubicin niosomes against an ovarian cancer cell line and three in vivo mouse tumour models.Characterisation of a navelbine-resistant bladder carcinoma cell line cross-resistant to taxoids.Chemotherapeutic efficacy of the protein-doxorubicin conjugates on multidrug resistant rat hepatoma cell line in vitro.Reversion of multidrug resistance with polyalkylcyanoacrylate nanoparticles: towards a mechanism of action.Immunohistochemical detection of P-glycoprotein in formalin-fixed and paraffin-embedded normal and neoplastic canine tissues.Polymeric nanoparticulate system augmented the anticancer therapeutic efficacy of gemcitabine.Enhanced brain tumor selectivity of cationic magnetic polysaccharide microspheres.Preparation and optimization of doxorubicin-loaded albumin nanoparticles using response surface methodology.Safety and efficacy of intra-arterial hepatic chemotherapy with doxorubicin-loaded nanoparticles in hepatocellular carcinoma.
P2860
Q26828930-2B92B2CE-CE00-4B42-88CC-05E1341744D7Q26830028-1297B91D-5545-4057-82D7-0E9F1EC727E3Q27012455-105DEAA6-BB58-4677-8E4A-DB8FE30878E2Q33358484-C5C246E5-7ED3-4E4A-B4B3-ACD68487164BQ33957314-4858951D-115A-48AB-99D5-942B3F507458Q34122203-21ACD893-2D21-465A-8729-A390885CEE05Q35127787-C4134E2B-FB22-4801-A133-668FD5DAA03FQ35609201-8326B96A-87DC-4DB4-AF8D-480D98DEF13FQ35664688-BCAE0DFC-CBC7-4A52-B78E-61C1BEA385A6Q37031597-817E8600-6071-4D87-BFBB-39ED8E47693AQ37062606-C5AE5E4B-3525-4DA8-B2BE-E3A0382D5D6EQ37672446-C448D1C6-7DCD-4C51-876B-8998E1B74D3AQ37765187-8F634FC2-A2BD-434F-BE2A-43C3092F2EF3Q38131264-BB50B5EC-3C44-45B4-B40F-4EE32850DA78Q38721673-AD1A143A-B25D-4548-A6D0-B003BB432118Q38980088-2757896F-15AB-4FFD-854D-5BEB61D629FFQ39616068-4000FD05-F993-4BBE-AF2E-1301444C9B67Q39711516-03B42522-5F2A-47B0-8FA6-E9B797AB1B55Q39757347-B9EDD027-5A2D-439E-B2AE-64B847B6C1C9Q40117111-AA5757A6-4D57-498A-AB6A-004987FAC315Q41247187-C7CF0AB9-C540-4EDC-A05D-40E7859ECCB3Q41415335-A8717CDB-BB11-4967-BF94-BBF8C61A2E56Q41575583-DE3DF994-C36F-4AB9-8F9A-B69F582D9D12Q41912317-61E17DDC-78D2-41C3-AEA5-629D8D2A0921Q42525924-D771A42B-A715-47AA-B7BA-D11EBFC51B7CQ43289065-4205B35A-B20D-4D76-9182-640AE2F4BB86Q48306067-6FC321B5-8E2B-4102-A666-233BFCFF9C66Q51584060-5CF4A984-1146-4958-844E-400FDB7748A3Q55266511-157F1B6B-FF28-4AB4-B857-8BE4AA035237
P2860
Doxorubicin-loaded nanospheres bypass tumor cell multidrug resistance.
description
1992 nî lūn-bûn
@nan
1992 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Doxorubicin-loaded nanospheres bypass tumor cell multidrug resistance.
@ast
Doxorubicin-loaded nanospheres bypass tumor cell multidrug resistance.
@en
type
label
Doxorubicin-loaded nanospheres bypass tumor cell multidrug resistance.
@ast
Doxorubicin-loaded nanospheres bypass tumor cell multidrug resistance.
@en
prefLabel
Doxorubicin-loaded nanospheres bypass tumor cell multidrug resistance.
@ast
Doxorubicin-loaded nanospheres bypass tumor cell multidrug resistance.
@en
P2093
P1476
Doxorubicin-loaded nanospheres bypass tumor cell multidrug resistance.
@en
P2093
Chevillard S
Couvreur P
Roblot-Treupel L
P304
P356
10.1016/0006-2952(92)90443-M
P407
P577
1992-08-01T00:00:00Z